WellSpan and Johns Hopkins renew partnership for advanced cancer care access
The collaboration will reach patients in the Central Susquehanna Valley, where WellSpan is investing in oncology services.
Drug Development
Charles River and MVC to develop enterovirus vaccine
FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy
SandboxAQ introduces AQPotency for virtual drug screening
Andelyn Biosciences to develop GM2 gangliosidosis therapy
BeOne Medicines and partners renew Brukinsa access programme for CLL
Faeth’s PIKTOR plus paclitaxel combo gains FDA fast track status
Fulcrum and Slate Medicines sign merger agreement
